Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders. Our drug discovery and development platform identifies and develops allosteric modulators — molecules that increase or decrease the activity of target receptors by binding outside of the “active site” where endogenous ligands and traditional drugs operate. Through this platform, Neurosterix’s novel drug candidates have the potential to provide medicines with improved efficacy, safety and tolerability for patient communities suffering from underserved neurological disorders.
Company Details
- Employees
- 20
- Founded
- -
- Address
- Chemin Des Mines 9, Geneva,geneva 1202,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.neurosterix.com/
- HQ
- Geneva, Geneva
Neurosterix Questions
Neurosterix's website is https://www.neurosterix.com/
Neurosterix's LinkedIn profile is https://ch.linkedin.com/company/neurosterix
Neurosterix has
20 employees.
View email and phone details for 20
employees at Neurosterix.
Neurosterix's industry is
Biotechnology Research
Neurosterix's top competitors are
Orakl Oncology,
Asceneuron Sa,
Biow,
Ionctura,
Artica Therapeutics,
Amber Therapeutics,
Cellforcure By Seqens,
Alentis Therapeutics,
Cellclar Cic,
Addex Therapeutics.
Neurosterix's categories are Biotechnology Research
Neurosterix's founding year is 2024
